Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
08.02. | TENARIS SA - 6-K, Report of foreign issuer | - | SEC Filings | ||
08.02. | PILGRIMS PRIDE CORP - 8-K, Current Report | - | SEC Filings | ||
08.02. | Primo Brands Corp - 8-K, Current Report | - | SEC Filings | ||
08.02. | Kaival Brands Innovations Group, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
08.02. | Rexford Industrial Realty, Inc. - 10-K, Annual Report | - | SEC Filings | ||
08.02. | Toleranzia AB: Toleranzia's clinical trial application (CTA) for TOL2 approved in Sweden | 53 | GlobeNewswire (Europe) | Toleranzia AB (the "Company" or "Toleranzia") today announces that the CTA, filed with the European Medicines Agency (EMA) for a clinical trial of the Company's investigational drug TOL2 in patients... ► Artikel lesen | |
08.02. | Regeneron Pharmaceuticals, Inc.: EYLEA HD (aflibercept) Injection 8 mg Positive Phase 3 Results in Patients with Macular Edema following Retinal Vein Occlusion Presented at Angiogenesis Meeting | 168 | GlobeNewswire (Europe) | TARRYTOWN, N.Y., Feb. 08, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the first presentation of positive results from the Phase 3 QUASAR trial investigating... ► Artikel lesen | |
08.02. | Regeneron Pharmaceuticals, Inc.: Three-Year Results for EYLEA HD (aflibercept) Injection 8 mg in Patients with Wet Age-related Macular Degeneration Demonstrate Continued Durable Vision Gains and Anatomic Improvements with ... | 152 | GlobeNewswire (Europe) | At three years of EYLEA HD treatment, the vast majority of patients maintained visual and anatomic improvements while achieving extended dosing regimens, including those of just twice a year: 77%... ► Artikel lesen | |
08.02. | 4D Molecular Therapeutics, Inc.: 4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program | 142 | GlobeNewswire (Europe) | 3E10 vg/eye achieved an 83% reduction in injection burden vs. projected on-label aflibercept 2 mg Q8W, 70% required 0-1 supplemental injection, and 57% were injection-free through 52 weeksIn the recently... ► Artikel lesen | |
08.02. | DASIN RETAIL TRUST: GENERAL ANNOUNCEMENT::UPDATE ON RECEIPT OF REQUISITION FOR AN EGM OF UNITHOLDERS | - | SGX Company Announcements | ||
08.02. | PHILLIP CAPITAL MANAGEMENT (S) LTD: GENERAL ANNOUNCEMENT::NET TANGIBLE ASSETS (NTA) PER UNIT | - | SGX Company Announcements | ||
08.02. | BHARTI AIRTEL LIMITED: GENERAL ANNOUNCEMENT::ALLOTMENT OF EQUITY SHARES UPON CONVERSION OF USD 1,000 MILLION 1.50% CONVERTIBLE BONDS DUE 2025 | - | SGX Company Announcements | ||
08.02. | Gold ist nicht zu stoppen | 223 | Claus Vogt | * Ein weiteres Gold-Jahr hat begonnen * Trump kürzt Staatsausgaben * Gold als Underdog * Es ist noch nicht zu spät für den Einstieg Liebe Leser,Mitte dieser Woche ist es schon wieder passiert: Mit einem... ► Artikel lesen | |
08.02. | Meta plans to lay off five percent of staff from Monday, hire machine learning engineers | 7 | DatacenterDynamics | ||
08.02. | PlayStation Network suffers major global outage lasting more than a day | 3 | DatacenterDynamics | ||
08.02. | Erschöpft? Hodl BTC und Berühre Gras | 1 | Bitcoin.com News | ||
08.02. | Half of the S&P 500 real estate stocks post earnings beat - Earnings Scorecard | 2 | Seeking Alpha | ||
08.02. | «De Sänf dezue»: Tele M1 startet neuen regionalen Polit-Talk | 2 | Klein Report | ||
08.02. | XRP: Steht ein massiver Kursanstieg bevor? | 4 | IT BOLTWISE | ||
08.02. | SpaceX bereitet sich auf den Start von Starlink-Satelliten in Florida vor | 1 | IT BOLTWISE |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 736 |
EVOTEC | 402 |
NOVO NORDISK | 380 |
TESLA | 352 |
RHEINMETALL | 312 |
BYD | 289 |
RENK GROUP | 200 |
DEUTZ | 198 |
BAYER | 172 |
BASF | 160 |
TUI | 159 |
APPLE | 155 |
STEYR MOTORS | 154 |
VOLKSWAGEN | 151 |
NETFLIX | 148 |
PLUG POWER | 143 |
AMAZON | 139 |
ALMONTY | 137 |
COMMERZBANK | 133 |
NEL | 132 |
UNITEDHEALTH | 132 |
XIAOMI | 130 |
DEUTSCHE BANK | 129 |
E.ON | 128 |
RWE | 125 |